Skip to content

Determination of thrombin production capacity in artificial heart lungs by the high-sensitivity thrombin test

Determination of thrombin production capacity in artificial heart lungs by the high-sensitivity thrombin test - Determine

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000057103
Enrollment
25
Registered
2025-03-01
Start date
2025-02-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing cardiovascular surgery using an artificial heart-lung

Interventions

None listed

Sponsors

National Cerebral and Cardiovascular Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Cardiovascular surgery patients over 20 years of age 2) Patients at high risk of thrombosis or with concomitant thrombosis

Exclusion criteria

Exclusion criteria: 1) Subject patients with congenital coagulation factor abnormalities such as hemophilia 2) Patients under intubation sedation 3) Patients deemed by the investigator to be inappropriate to participate in this study for other reasons

Design outcomes

Primary

MeasureTime frame
Thrombin production capacity during artificial cardiopulmonary

Countries

Japan

Contacts

Public ContactTakuma Maeda

National Cerebral and Cardiovascular Center Department of Anesthesia

takuma@ncvc.go.jp0661701070

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026